Amlodipine Besylate Tablet
Product Images NDC 63629-1024

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 63629-1024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

This is a table showing results of a study with 1318 patients, where data is segmented by age, gender, baseline blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI status. The table includes the hazard ratio and confidence interval. The study favors Amlodipine over Placebo in patients with at least one vessel with >60% stenosis, but the opposite was observed when there was no vessel with stenosis. The mean sitting baseline SBP is 129 mmHg.*

FDA Label Image

Structure (Ima)

FDA Label Image

Label Image (Lbl636291024)

This is a drug description for Amlodipine Besylate Tablets, USP. Each tablet contains 5 mg of AMLODIPINE BESYLATE. The drug should be kept out of the reach of children and stored at temperatures between 20 to 25 degrees Celsius, with excursions permitted to 15° to 30° C. The tablets are available in a bottle 30 tablets and require a prescription to be obtained. The NDC number for this drug is 63629-1024-2.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.